PTEN activity could be a predictive marker of trastuzumab efficacy in the treatment of ErbB2-overexpressing breast cancer

✍ Scribed by Fujita, T; Doihara, H; Kawasaki, K; Takabatake, D; Takahashi, H; Washio, K; Tsukuda, K; Ogasawara, Y; Shimizu, N

• Book ID: 109998698
• Publisher: Nature Publishing Group
• Year: 2006
• Tongue: English
• Weight: 200 KB
• Volume: 94
• Category: Article
• ISSN: 0007-0920
• DOI: 10.1038/sj.bjc.6602926